UNICREDIT BANK/CALL/ELI LILLY & CO/1000/0.1/14.01.26 | Market Closed - Bid/Ask 01:11:10 03/07/2024 am IST | After market 01:29:46 am | |||
| 12 EUR | -1.80% |
|
12.16 | +1.37% |
| Current month | +0.25% | ||
| 1 month | +43.09% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
ELI LILLY AND COMPANY
Latest news about ELI LILLY AND COMPANY
| Date | Price | Change |
|---|---|---|
| 03/24/03 | 12 | -1.80% |
| 01/24/01 | 12.22 | +0.25% |
| 28/24/28 | 12.19 | +2.35% |
| 27/24/27 | 11.91 | +1.19% |
| 26/24/26 | 11.77 | -2.16% |
Real-time BOERSE MUENCHEN
Last update July 03, 2024 at 01:11 am IST
More quotesStatic data
| Product type | Warrants |
|---|---|
| Buy / Sell | CALL |
| Underlying | ELI LILLY AND COMPANY |
| Issuer | 
UniCredit
|
| WKN | HD28UU |
| ISIN | DE000HD28UU1 |
| Date issued | 29/01/2024 |
| Strike | 1,000 $ |
| Maturity | 14/01/2026 (561 Days) |
| Parity | 10 : 1 |
| Emission price | 3.85 € |
| Emission volume | N/A |
| Settlement | Por diferencias |
| Currency | EUR |
Technical Indicators
| Highest since issue | 12.22 € |
|---|---|
| Lowest since issue | 3.54 € |
| Delta | 0.55x |
| Omega | 3.787 |
| Premium | 24.72x |
| Gearing | 6.93x |
| Moneyness | 0.9067 |
| Difference Strike | 93.29 $ |
| Difference Strike % | +9.33% |
| Spread | 0.35 € |
| Spread % | 2.83% |
| Theoretical value | 12.17 |
| Implied Volatility | 31.91 % |
| Total Loss Probability | 60.56 % |
| Intrinsic value | 0.000000 |
| Present value | 12.17 |
| Break even | 1,130.72 € |
| Theta | -0.11x |
| Vega | 0.41x |
| Rho | 0.52x |
Company Profile
Eli Lilly and Company is one of the world's leading pharmaceutical groups. Net sales break down by therapeutic field as follows:
- endocrinology (57.7%): products for treating osteoporosis, diabetes, and growth problems;
- oncology (19.5%);
- immunology diseases (11.1%);
- neurology (8.4%): primarily drugs used in treating depression and schizophrenia;
- other (3.3%).
Net sales are distributed geographically as follows: the United States (63.9%), Europe (18.1%), Japan (4.9%), China (4.5%) and other (8.6%).
Sector
-
Consensus: Eli Lilly and Company
Sell
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
914.4
USD
Average target price
868.9
USD
Spread / Average Target
-4.97%
- Stock Market
- Warrants
- Warrant
